35 related articles for article (PubMed ID: 1869997)
1. Serum thyroglobulin and whole-body iodine-131 scan in the management of differentiated thyroid carcinoma.
Klein HA
J Nucl Med; 1991 Aug; 32(8):1645. PubMed ID: 1869997
[No Abstract] [Full Text] [Related]
2. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
Schlumberger M
J Nucl Med; 1992 Jan; 33(1):172-3. PubMed ID: 1571042
[No Abstract] [Full Text] [Related]
3. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer.
Aiello DP; Manni A
Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703
[TBL] [Abstract][Full Text] [Related]
4. 131I total body scan and serum thyroglobulin assay in the follow-up of surgically treated patients affected by differentiated thyroid carcinoma.
Panza N; Lombardi G; Minozzi M; Salvatore M; Claudio F; Mariano A; Macchia V
J Nucl Med Allied Sci; 1984; 28(1):9-12. PubMed ID: 6481470
[No Abstract] [Full Text] [Related]
5. Serum thyroglobulin in differentiated thyroid carcinoma.
Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
[TBL] [Abstract][Full Text] [Related]
6. [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms].
Hüfner M; Pollmann H; Grussendorf M; Schenk P
Schweiz Med Wochenschr; 1980 Feb; 110(5):159-62. PubMed ID: 7361086
[TBL] [Abstract][Full Text] [Related]
7. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
[TBL] [Abstract][Full Text] [Related]
8. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
9. Postsurgical management of differentiated thyroid carcinoma.
Mazzaferri EL; Robyn J
Otolaryngol Clin North Am; 1996 Aug; 29(4):637-62. PubMed ID: 8844735
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin measurements in the follow-up of patients with differentiated thyroid carcinoma: comparison with quantitative radioactive iodine uptake measurements and total body scans.
Bolk JH; Bussemaker JK; Nieuwenhuijzen Kruseman AC; De Vijlder JJ; Goslings BM
Neth J Med; 1985; 28(9):340-6. PubMed ID: 4047268
[No Abstract] [Full Text] [Related]
11. Constraints on the sensitivity and specificity of "logically" merged test results.
Metz CE
J Nucl Med; 1991 Aug; 32(8):1646-7. PubMed ID: 1869998
[No Abstract] [Full Text] [Related]
12. Comparison of serum thyroglobulin with iodine scans in thyroid cancer.
Charles MA
J Endocrinol Invest; 1982; 5(4):267-71. PubMed ID: 7175109
[No Abstract] [Full Text] [Related]
13. False-positive results of an iodine-131 whole-body scan caused by an ectopic kidney.
Attard M; Marozzi P; Gambino L; Janní F; Salice P; Ficola U; Giuffrida D
Clin Nucl Med; 2001 Mar; 26(3):271-3. PubMed ID: 11245137
[No Abstract] [Full Text] [Related]
14. Management of thyroglobulin-positive, body scan-negative thyroid cancer patients: evidence for the utility of I-131 therapy.
Robbins J
J Endocrinol Invest; 1999 Nov; 22(10):808-10. PubMed ID: 10614533
[No Abstract] [Full Text] [Related]
15. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan: Reply.
Sritara C
Clin Nucl Med; 2017 Mar; 42(3):241-242. PubMed ID: 28079570
[No Abstract] [Full Text] [Related]
16. Serum "thyroglobulin" in thyroidal carcinoma.
OWEN CA; McCONAHEY WM; CHILDS DS; McKENZIE BF
J Clin Endocrinol Metab; 1960 Feb; 20():187-204. PubMed ID: 14429540
[No Abstract] [Full Text] [Related]
17. Chemiluminescent assay for serum thyroglobulin in the management of patients with thyroid carcinoma.
Perry LA; Dawnay A
Clin Chem; 2001 Apr; 47(4):778-9. PubMed ID: 11274041
[No Abstract] [Full Text] [Related]
18. [Thyroglobulin labelled with radioiodine I 131].
ROCHE J; MICHEL O; MICHEL R
C R Seances Soc Biol Fil; 1950 Apr; 144(7-8):506-8. PubMed ID: 14773055
[No Abstract] [Full Text] [Related]
19. I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Verburg FA; Giovanella L; Iakovou I; Konijnenberg MW; Langsteger W; Lassmann M; Mihailovic J; Luster M
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2247-2249. PubMed ID: 30298378
[No Abstract] [Full Text] [Related]
20. Role of Preablative-Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-body Scan.
Bothra S; Mayilvaganan S
Indian J Nucl Med; 2018; 33(3):266. PubMed ID: 29962735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
